Back to results
US 2021/0267964 A1Published application
Nlrp3 modulators
AssigneeInnate Tumor Immunity, Inc.
InventorsYONG ZHANG, Ashvinikumar V. Gavai, Andrew F. Donnell, Shomir Ghosh, William R. Roush, Prasanna Sivaprakasam, Steven P. Seitz, Jay A. Markwalder
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula (I): wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).
Claims31
A compound of Formula (I):
- or a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof, wherein:
- is independently selected from:
- R1 is, at each occurrence, independently:
- (i) H;
- (ii) halo;
- (iii) X—R5, wherein X is C1-6 alkylene, and R5 is H, OH, cyano, C1-4 alkoxy, C1-4 haloalkoxy, —C(O)ORa, —NRbRc, or —C(O)NRbRk;
- (iv) C1-6 alkyl substituted with 1 to 6 F;
- (v) C3-6 cycloalkyl substituted with 0 to 6 F;
- (vi) (C1-3 alkylene)-aryl, wherein the aryl is substituted with 0 to 3 Rd;
- or
- (vii) (C1-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Rf), O, and S, wherein the heteroaryl is substituted with 0 to 3 Rd;
- R1a is independently H, C1-6 alkyl substituted with 0 to 6 F, or C3-6 cycloalkyl substituted with 0 to 6 F;
- R2 is, at each occurrence, independently:
- (i) H;
- (ii) —Y—R6;
- (iii) —C(O)—Y—R6;
- wherein:
- Y is independently C1-8 alkylene substituted with from 0 to 4 Re;
- and
- R6 is, at each occurrence, independently:
- H, OH, CN, ORa, —C(O)Ra, —C(O)ORa, —NRbRc, —C(O)NRbRk, —SO1-2Rh
- or heteroaryl including from 5 to 10 ring atoms, wherein from 1-4 ring atoms are each independently selected from N, N(Rf), O, and S, wherein the heteroaryl is substituted with from 0 to 3 Rd;
- (iv) —(Y1)n—Y2—(Y3)p—R7, wherein:
- n is independently 0, 1 or 2;
- p is independently 0 or 1;
- each of Y1 and Y3 is, independently, C1-3 alkylene substituted with from 0 to 2 Re;
- Y2 is independently C3-6 cycloalkylene substituted with from 0 to 4 Rg, or heterocycloalkylene including from 3-8 ring atoms, wherein from 1-2 ring atoms are each independently selected from N, N(Rf) and O, and wherein the heterocycloalkylene is substituted with from 0 to 4 Rg, and
- R7 is H, OH, —ORa, —C(O)ORa, —NRbRc, —C(O)NRbRk, or heteroaryl including from 5-6 ring atoms, wherein from 1-4 ring atoms are each independently selected from N, N(Rf), O, and S, and wherein the heteroaryl is substituted with from 0 to 4 Rg;
- or
- (v) —Z1—Z2—Z3—R8, wherein:
- Z1 is C1-3 alkylene substituted with from 0 to 6 F;
- Z2 is —N(Rf)—, —O—, or —S—;
- Z3 is C2-5 alkylene substituted with from 0 to 6 F;
- and
- R8 is OH, ORa, —C(O)Ra, —C(O)ORa;
- —NRbRc, —C(O)NRbRk, or heteroaryl including from 5-6 ring atoms, wherein from 1-4 ring atoms are each independently selected from N, N(Rf), O, and S, wherein the heteroaryl is substituted with from 0 to 3 Rd;
- R3 is independently halo or —(C0-3 alkylene)-(5-membered heteroaryl) wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from:
- N, N(Rf), O, and S, and is substituted with from 0 to 3 Rg;
- provided that when R3 is furanyl, R2 is other than C1-4 alkyl;
- R4 is independently selected from:
- H, halo, cyano, OH, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, —C(O)OH, —C(O)ORa, —NRjRk, —C(O)NRjRk, —SO1-2Rh, and C1-4 alkyl substituted with from 0 to 2 Re;
- Ra is, at each occurrence, independently:
- (i) C1-6 alkyl substituted with from 0 to 3 Re;
- (ii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is substituted with from 0 to 4 Rg;
- (iii) —(C0-3 alkylene)-heterocyclyl including from 3 to 10 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Rf), O, and S(O)0-2, wherein the heterocyclyl is substituted with from 0 to 4 Rg;
- (iv) —(C0-3 alkylene)—(C6-10 aryl), wherein the aryl is substituted with from 0 to 5 Rd;
- or
- (v) —(C0-3 alkylene)-heteroaryl including from 5 to 10 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Rf), O, and S, wherein the heteroaryl is substituted with from 0 to 3 Rd;
- Rb is, at each occurrence, independently H or Ra;
- Rc is, at each occurrence, independently selected from:
- H, —C(O)Ra, —C(O)ORa, —C(O)NjRk, —S(O)1-2Rh, C1-6 alkyl substituted with from 0 to 2 Re, —(C0-3 alkylene)-(phenyl substituted with from 0 to 4 Rn), and —(C0-3 alkylene)-heteroaryl including from 5-6 ring atoms, wherein from 1-4 ring atoms are each independently selected from N, N(Rf), O, and S, wherein the heteroaryl is substituted with from 0 to 3 Rn;
- alternatively, Rb and Rc, together with the nitrogen atom to which each is attached form heterocyclyl including from 3 to 10 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Rf), O, and S, and wherein the heterocyclyl is substituted with from 0 to 4 Rg;
- Rd is, at each occurrence, independently selected from:
- halo, OH, cyano, C2-6 alkenyl, C2-6 alkynyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, —C(O)(C1-4 alkyl), —C(O)OH, —C(O)O(C1-4 alkyl), —NRjRk, —N(Rm)(C(O)(C1-4 alkyl), —N(Rm)(C(O)O(C1-4 alkyl), —C(O)NRjRk, —S(O)1-2Rh, —S(O)1-2NRhRj, C1-6 alkyl substituted with from 0 to 2 Re, and —(C0-3 alkylene)-Rp;
- Re is, at each occurrence, independently selected from:
- halo, OH, cyano, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, —C(O)ORa, —OC(O)Rh, —NRbRc, and —CONRbRk;
- Rf is, at each occurrence, independently selected from:
- H, OH, C1-4 alkyl, C1-4 alkoxy, —C(O)(C1-4 alkyl), —C(O)(C1-4 haloalkyl), —C(O)O(C1-4 alkyl), —C(O)NRjRk, —S(O)1-2Rh, and —(C0-3 alkylene)-phenyl;
- Rg is, at each occurrence, independently oxo or Rd;
- Rh is, at each occurrence, independently selected from C1-6 alkyl substituted with 0 to 2 Rn, C1-4 haloalkyl, and —(C0-3 alkylene)-Rp;
- Rj and Rm are, at each occurrence, independently H or C1-4 alkyl;
- Rk is, at each occurrence, independently selected from H, C1-4 alkyl, and —(C0-2 alkylene)-phenyl;
- Rn is, at each occurrence, independently selected from:
- halo, OH, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, —C(O)OH, —C(O)O(C1-4 alkyl), —NRjRk, and —CONRjRk;
- and
- Rp is, at each occurrence, independently selected from:
- C3-6 cycloalkyl substituted with from 0 to 4 C1-4 alkyl;
- heterocyclyl including from 3-10 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from NH, N(C1-4 alkyl), O, and S, wherein the heterocyclyl is substituted with 0 to 4 independently selected C1-4 alkyl;
- phenyl substituted with 0 to 3 Rn;
- and heteroaryl including from 5 to 10 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, NH, N(C1-4 alkyl), O, and S, wherein the heteroaryl is substituted with 0 to 3 Rn.
67 more elements
(canceled)
Dependencies are inferred from the claim text.